Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Invesco Ltd. Director's Dealing 2019

Feb 12, 2019

10507_dirs_2019-02-12_c6c3a301-3b77-4660-9700-7da7197c801c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evofem Biosciences, Inc. (EVFM)
CIK: 0001618835
Period of Report: 2019-02-08

Reporting Person: Invesco Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-08 Common stock P 425531 $2.64 Acquired 9590688 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-08 Warrants $5.20 P 212765 Acquired 2026-02-08 Common Stock (212765) Indirect

Footnotes

F1: Invesco Ltd. is the beneficial owner of 9,590,688 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.

F2: The warrants are exercisable on the earlier of 08/08/2019, or following the date that the issuance of the warrants is approved by the stockholders of the Issuer.